Spots Global Cancer Trial Database for A Study of Teclistamab in Japanese Participants With Relapsed or Refractory Multiple Myeloma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of Teclistamab in Japanese Participants With Relapsed or Refractory Multiple Myeloma
Official Title: A Phase 1/2 Study of JNJ-64007957, a Humanized BCMA * CD3 Bispecific Antibody in Japanese Patients With Relapsed or Refractory Multiple Myeloma
Study ID: NCT04696809
Conditions
Interventions
Study Description
Brief Summary: The purpose of the study is to evaluate the safety and tolerability in Japanese participants with relapsed or refractory multiple myeloma (RRMM) at the recommended Phase 2 dose (RP2D) identified in Study 64007957MMY1001 (NCT03145181) in Phase 1 part and to evaluate the efficacy of teclistamab at RP2D for Japanese participants in Phase 2 part.
Detailed Description:
Keywords
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Kameda General Hospital, Chiba, , Japan
Ogaki Municipal Hospital, Gifu, , Japan
National Hospital Organization Mito Medical Center, Higashiibaraki-gun, , Japan
Kobe City Medical Center General Hospital, Hyogo, , Japan
National Hospital Organization Kumamoto Medical Center, Kumamoto-shi, , Japan
Kurume University Hospital, Kurume, , Japan
Kyoto Kuramaguchi Medical Center, Kyoto, , Japan
National Hospital Organization Matsumoto Medical Center, Matsumoto, , Japan
Nagoya City University Hospital, Nagoya-City, , Japan
Niigata Cancer Center Hospital, Niigata, , Japan
National Hospital Organization Okayama Medical Center, Okayama, , Japan
Osaka International Cancer Institute, Osaka, , Japan
Japanese Red Cross Osaka Hospital, Osaka, , Japan
Hiroshima West Medical Center, Otake, , Japan
Japanese Red Cross Medical Center, Shibuya, , Japan
Contact Details
Name: Janssen Pharmaceutical K.K., Japan Clinical trials
Affiliation: Janssen Pharmaceutical K.K.
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
